FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Hacène Khiri

Research Profile

Living Beings

Chemicals & Drugs

Disorders

Concepts & Ideas

Physiology

Genotype

Procedures

Geographic Areas

France

Co-author Network

Publications

TOP 3
Sofiane Mohamed; Daniel Olive; Denis Ouzan; Guillaume Pénaranda; Audrey Raimondo; Sophie Ravet; Marc Bourlière; Claire Camus; Patrick Dukan; Hacène Khiri; Philippe Halfon
Dried blood spot sampling for hepatitis B virus serology and molecular testing.
Philippe Halfon; Asma Kahloun; Hacène Khiri; Agnès Martineau; Lou Naldi; Valerie Oulès; Denis Ouzan; Guillaume Pénaranda; Nolwenn Amrani; Paul Castellani; Lise Fanteria; Marc Bourlière
Detection of IL28B SNP DNA from buccal epithelial cells, small amounts of serum, and dried blood spots.
Philippe Halfon; Michelle Martinot-Peignoux; Hacène Khiri; Patrick Marcellin
Quantification of genotype 4 serum samples: Impact of hepatitis C virus genetic variability.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Hacène Khiri (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Sofiane Mohamed; Daniel Olive; Denis Ouzan; Guillaume Pénaranda; Audrey Raimondo; Sophie Ravet; Marc Bourlière; Claire Camus; Patrick Dukan; Hacène Khiri; Philippe Halfon
Dried blood spot sampling for hepatitis B virus serology and molecular testing.
PloS one 2013;8(4):e61077.
2012: Philippe Halfon; Asma Kahloun; Hacène Khiri; Agnès Martineau; Lou Naldi; Valerie Oulès; Denis Ouzan; Guillaume Pénaranda; Nolwenn Amrani; Paul Castellani; Lise Fanteria; Marc Bourlière
Detection of IL28B SNP DNA from buccal epithelial cells, small amounts of serum, and dried blood spots.
PloS one 2012;7(3):e33000.
2010: Philippe Halfon; Michelle Martinot-Peignoux; Hacène Khiri; Patrick Marcellin
Quantification of genotype 4 serum samples: Impact of hepatitis C virus genetic variability.
Hepatology (Baltimore, Md.) 2010;52(1):401.
2010: Philippe Halfon; Dominique Benmoura; Aubert Agostini; Hacène Khiri; Agnés Martineau; Guillaume Penaranda; Bernard Blanc
Relevance of HPV mRNA detection in a population of ASCUS plus women using the NucliSENS EasyQ HPV assay.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2010;47(2):177-81.
2010: Philippe Halfon; Hacène Khiri; Guillaume Penaranda; Sophie Ravet; Carole Lefoll
Incident HPV 51 Infection After Prophylactic Quadrivalent Human Papillomavirus (Types 6, 11, 16, and 18) L1 Virus-Like Particle Vaccine Gardasil/Silgard.
Clinical medicine insights. Case reports 2010;3():69-71.
2010: Philippe Halfon; Dominique Benmoura; Aubert Agostini; Hacène Khiri; Guillaume Pénaranda; Agnès Martineau; Bernard Blanc
Stepwise algorithm combining HPV high-risk DNA-based assays and RNA-based assay for high grade CIN in women with abnormal smears referred to colposcopy.
Cancer biomarkers : section A of Disease markers 2010;7(3):133-9.
2010: Philippe Halfon; Claude Giorgetti; Hacène Khiri; Guillaume Pénaranda; Philippe Terriou; Géraldine Porcu-Buisson; Véronique Chabert-Orsini
Semen may harbor HIV despite effective HAART: another piece in the puzzle.
PloS one 2010;5(5):e10569.
2009: Michèle Martinot-Peignoux; Hacène Khiri; Laurence Leclere; Sarah Maylin; Patrick Marcellin; Philippe Halfon
Clinical performances of two real-time PCR assays and bDNA/TMA to early monitor treatment outcome in patients with chronic hepatitis C.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2009;46(3):216-21.
2008: Philippe Halfon; Marc Bourlière; Hacène Khiri; Guillaume Pénaranda; Agnes Martineau; Valérie Oulès; Jérôme Courcambeck; Patrick Philibert
Mutation rate in hepatitis C virus NS3 protease is not influenced by HIV-1 protease inhibitor therapy.
AIDS (London, England) 2008;22(13):1694-6.
2008: Philippe Halfon; Marc Bourlière; Denis Ouzan; Damien Sène; David Saadoun; Hacène Khiri; Guillaume Pénaranda; Agnes Martineau; Valérie Oulès; Patrice Cacoub
Occult hepatitis C virus infection revisited with ultrasensitive real-time PCR assay.
Journal of clinical microbiology 2008;46(6):2106-8.
2008: Jean-Pierre Bronowicki; Idrissia Abdelmouttaleb; Laurent Peyrin-Biroulet; Véronique Venard; Hacène Khiri; Nicodème Chabi; Emile K Amouzou; Hélène Barraud; Philippe Halfon; Ambaliou Sanni; Marc-André Bigard; Alain Le Faou; Jean-Louis Guéant
Methylenetetrahydrofolate reductase 677 T allele protects against persistent HBV infection in West Africa.
Journal of hepatology 2008;48(4):532-9.
2007: Philippe Halfon; Elisabeth Trepo; Gilles Antoniotti; Catherine Bernot; Philippe Cart-Lamy; Hacène Khiri; Didier Thibaud; Jean Marron; Agnès Martineau; Guillaume Pénaranda; Dominique Benmoura; Bernard Blanc
Prospective evaluation of the Hybrid Capture 2 and AMPLICOR human papillomavirus (HPV) tests for detection of 13 high-risk HPV genotypes in atypical squamous cells of uncertain significance.
Journal of clinical microbiology 2007;45(2):313-6.
2006: Philippe Halfon; Nicolas Limal; Guillaume Penaranda; Hacène Khiri; Damien Sene; M Andreu; JM Feryn; Michel Rotily; R Serra; Jean-Charles Piette; Patrice Cacoub
Chronic Chlamydia pneumoniae infection in patients with symptomatic atherothrombosis.
The Journal of infection 2006;53(2):93-7.
2006: Philippe Halfon; Marc Bourlière; Guillaume Pénaranda; Hacène Khiri; Denis Ouzan
Real-time PCR assays for hepatitis C virus (HCV) RNA quantitation are adequate for clinical management of patients with chronic HCV infection.
Journal of clinical microbiology 2006;44(7):2507-11.
2006: Philippe Halfon; Marc Bourlière; S Pol; Y Benhamou; Denis Ouzan; Michel Rotily; Hacène Khiri; Christophe Renou; Guillaume Pénaranda; David Saadoun; Vincent Thibault; J Serpaggi; M Varastet; Marie-Hélène Tainturier; Thierry Poynard; Patrice Cacoub
Multicentre study of hepatitis B virus genotypes in France: correlation with liver fibrosis and hepatitis B e antigen status.
Journal of viral hepatitis 2006;13(5):329-35.
2006: Philippe Halfon; Guillaume Pénaranda; Marc Bourlière; Hacène Khiri; Marie-France Masseyeff; Denis Ouzan
Assessment of early virological response to antiviral therapy by comparing four assays for HCV RNA quantitation using the international unit standard: implications for clinical management of patients with chronic hepatitis C virus infection.
Journal of medical virology 2006;78(2):208-15.
2006: Philippe Halfon; Claude Giorgetti; Marc Bourlière; Véronique Chabert-Orsoni; Hacène Khiri; Guillaume Pénaranda; Jean-Marc Chincholle; Hervé Gallais; Isabelle Ravaux; Jacques Moreau; Jean-Albert Gastaud; Roger Roulier
Medically assisted procreation and transmission of hepatitis C virus: absence of HCV RNA in purified sperm fraction in HIV co-infected patients.
AIDS (London, England) 2006;20(2):241-6.
2006: René Gerolami; Marc Bourliere; Philippe Colson; Philippe Halfon; Patrick Borentain; Mireille Henry; Danielle Botta; Vincent Thibault; Hacène Khiri; Catherine Tamalet
Unusual selection of rtA181V HBV mutants cross-resistant to adefovir following prolonged lamivudine monotherapy: report of two cases.
Antiviral therapy 2006;11(8):1103-6.
2005: Patrice Cacoub; David Saadoun; Marc Bourlière; Hacène Khiri; Agnes Martineau; Yves Benhamou; Marina Varastet; Stanislas Pol; Vincent Thibault; Michel Rotily; Philippe Halfon
Hepatitis B virus genotypes and extrahepatic manifestations.
Journal of hepatology 2005;43(5):764-70.
2005: Philippe Halfon; Guillaume Pénaranda; Hacène Khiri; Bernard Xerridat
Long-term persistence of HIV with drug resistance after CD4 cell count-guided structured treatment interruption.
AIDS (London, England) 2005;19(15):1713-4.
2005: Denis Ouzan; Hacène Khiri; Guillaume Pénaranda; Hélène Joly; Philippe Halfon
Kinetics of hepatitis C virus RNA load during pegylated interferon alpha-2a and ribavirin treatment in naïve genotype 1 patients.
Comparative hepatology 2005;4():9.
2003: Philippe Halfon; Hacène Khiri; Albert Tran; Guillaume Pénaranda; Jérôme Courcambeck; Hélene Joly; Denis Ouzan
Hepatitis C virus RNA load in relapsed patients: week two of treatment is the best time to predict the complete response.
European journal of gastroenterology & hepatology 2003;15(10):1067-71.
2003: P Halfon; A U Neumann; Marc Bourlière; Alain Rieu; Stéphane Chadapaud; Hacène Khiri; Denis Ouzan; P Cacoub
Slow viral dynamics of hepatitis C virus genotype 4.
Journal of viral hepatitis 2003;10(5):351-3.
2003: Philippe Halfon; Jacques Durant; Philippe Clevenbergh; Hélène Carsenti; Linda Celis; Hacène Khiri; Koen A De Smet; Annelies De Brauwer; Frank Hulstaert; Pierre Dellamonica
Kinetics of disappearance of resistance mutations and reappearance of wild-type during structured treatment interruptions.
AIDS (London, England) 2003;17(9):1351-61.
2003: P Cacoub; Eric Rosenthal; Victoria Gerolami; Pierre Hausfater; Pascale Ghillani; Y Sterkers; Vincent Thibault; Hacène Khiri; J C Piette; Philippe Halfon
Transfusion-associated TT virus co-infection in patients with hepatitis C virus is associated with type II mixed cryoglobulinemia but not with B-cell non-Hodgkin lymphoma.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2003;9(1):39-44.
2003: P Cacoub; Marc Bourlière; Pierre Hausfater; Frédéric Charlotte; Hacène Khiri; S Toci; J C Piette; T Poynard; P Halfon
Lower expression of CD81 B-cell receptor in lymphoproliferative diseases associated with hepatitis C virus infection.
Journal of viral hepatitis 2003;10(1):10-5.
2002: Philippe Halfon; Marc Bourlière; Hacène Khiri; Gilles Halimi; Victoria Gerolami; JM Feryn; Denis Ouzan
Serological response to infection with different isolates of hepatitis C virus.
Journal of viral hepatitis 2002;9(6):438-42.
2002: Pascale Trimoulet; Philippe Halfon; Eric Pohier; Hacène Khiri; Geneviève Chêne; Hervé Fleury
Evaluation of the VERSANT HCV RNA 3.0 assay for quantification of hepatitis C virus RNA in serum.
Journal of clinical microbiology 2002;40(6):2031-6.
2002: Philippe Halfon; Christa Roubicek; Victoria Gerolami; Yves Quentin; Hacène Khiri; Gérad Pepe; Yvon Berland
Use of phylogenetic analysis of hepatitis C virus (HCV) hypervariable region 1 sequences to trace an outbreak of HCV in an autodialysis unit.
Journal of clinical microbiology 2002;40(4):1541-5.
2002: Marc Bourlière; J M Barberin; Michel Rotily; Valérie Guagliardo; Isabelle Portal; Laurence Lecomte; Souad Benali; Christian Boustière; Hervé Perrier; Monique Jullien; Gérard Lambot; R Loyer; O LeBars; R Daniel; Hacène Khiri; Philippe Halfon
Epidemiological changes in hepatitis C virus genotypes in France: evidence in intravenous drug users.
Journal of viral hepatitis 2002;9(1):62-70.
2001: Alain Lafeuillade; Hacène Khiri; Stéphane Chadapaud; Gilles Hittinger; Philippe Halfon
Persistence of HIV-1 resistance in lymph node mononuclear cell RNA despite effective HAART.
AIDS (London, England) 2001;15(15):1965-9.
2001: Alain Lafeuillade; Philippe Halfon; Stéphane Chadapaud; Gilles Hittinger; Hacène Khiri; Cécile Poggi
Potential adverse effects of structured therapeutic interruptions on the pool of HIV-infected cells.
Journal of acquired immune deficiency syndromes (1999) 2001;28(2):197-8.
2001: Alain Lafeuillade; Cécile Poggi; Stéphane Chadapaud; Gilles Hittinger; Hacène Khiri; P Halfon
Impact of immune interventions on proviral HIV-1 DNA decay in patients receiving highly active antiretroviral therapy.
HIV medicine 2001;2(3):189-94.
2001: Philippe Halfon; Pascale Trimoulet; Marc Bourliere; Hacène Khiri; Victor de Lédinghen; P Couzigou; JM Feryn; P Alcaraz; Christophe Renou; H J Fleury; Denis Ouzan
Hepatitis C virus genotyping based on 5' noncoding sequence analysis (Trugene).
Journal of clinical microbiology 2001;39(5):1771-3.
2000: Philippe Halfon; Gilles Halimi; Marc Bourlière; Denis Ouzan; Jacques Durant; Hacène Khiri; Laurence Mercier; Victoria Gerolami; G Cartouzou
Integrity of the NS5A (amino acid 2209 to 2248) region in hepatitis C virus 1b patients non-responsive to interferon therapy.
Liver 2000;20(5):381-6.
2000: Marc Bourlière; Philippe Halfon; Yves Quentin; P David; C Mengotti; Isabelle Portal; Hacène Khiri; Souad Benali; Hervé Perrier; Christian Boustière; Monique Jullien; Gérard Lambot
Covert transmission of hepatitis C virus during bloody fisticuffs.
Gastroenterology 2000;119(2):507-11.
1999: Philippe Halfon; Yves Quentin; Bertrand Roquelaure; Jacques Sarles; Gilles Halimi; Victoria Gerolami; Hacène Khiri; Marc Bourlière; G Cartouzou
Mother-to-infant transmission of hepatitis C virus: molecular evidence of superinfection by homologous virus in children.
Journal of hepatology 1999;30(6):970-8.
1999: Philippe Halfon; Marc Bourliere; JM Feryn; Hacène Khiri; M Chanas; J M Salvadori; Denis Ouzan
Prevalence of transmitted transfusion virus (TTV) in populations at different risk for hepatitis virus: hemodialysis, chronic hepatitis C and cryptogenetic hepatitis patients.
Journal of hepatology 1999;30(3):552.
1998: Philippe Halfon; Marc Bourlière; Gilles Halimi; Hacène Khiri; P Bertezene; Isabelle Portal; Danielle Botta-Fridlund; A P Gauthier; Monique Jullien; JM Feryn; Victoria Gerolami; G Cartouzou
Assessment of spontaneous fluctuations of viral load in untreated patients with chronic hepatitis C by two standardized quantitation methods: branched DNA and Amplicor Monitor.
Journal of clinical microbiology 1998;36(7):2073-5.
1998: Philippe Halfon; Hacène Khiri; JM Feryn; C Sayada; M Chanas; Denis Ouzan
Prospective virological follow-up of hepatitis C infection in a haemodialysis unit.
Journal of viral hepatitis 1998;5(2):115-21.
1997: Philippe Halfon; Marc Bourliere; J J Raabe; Hacène Khiri; Victoria Gerolami; G Cartouzou; JM Feryn; Denis Ouzan
Transmission of hepatitis G virus in HCV-infected couples: myth or reality?
Journal of hepatology 1997;27(2):427.
1997: Philippe Halfon; Denis Ouzan; Hacène Khiri; JM Feryn
Serotyping and genotyping of hepatitis C virus (HCV) strains in chronic HCV infection. Commission Hepatologie du CREGG. Club de Reflexion des Cabinets de Groupes en GastroEnterologie.
Journal of medical virology 1997;52(4):391-5.
1996: Philippe Halfon; M Levy; M San Marco; Victoria Gerolami; Hacène Khiri; Marc Bourliere; JM Feryn; J L Gastaut; J Pouget; G Cartouzou
Myasthenia gravis and hepatitis C virus infection.
Journal of viral hepatitis 1996;3(6):329-32.
1996: Philippe Halfon; Hacène Khiri; Victoria Gerolami; Marc Bourliere; JM Feryn; Pascal Reynier; A Gauthier; G Cartouzou
Impact of various handling and storage conditions on quantitative detection of hepatitis C virus RNA.
Journal of hepatology 1996;25(3):307-11.
1996: Hacène Khiri; Pascal Reynier; N Peyrol; B Lerique; Janine Torresani; Richard Planells
Quantitative multistandard RT-PCR assay using interspecies polymorphism.
Molecular and cellular probes 1996;10(3):201-11.
1995: J F Rey; Philippe Halfon; JM Feryn; Hacène Khiri; M F Masseyeff; D Ouzan
[Risk of transmission of hepatitis C virus by digestive endoscopy].
Gastroentérologie clinique et biologique 1995;19(4):346-9.
1994: Philippe Halfon; Denis Ouzan; M Chanas; Hacène Khiri; JM Feryn; L Mangin; M F Masseyef; J M Salvadori
High prevalence of hepatitis E virus antibody in haemodialysis patients.
Lancet 1994;344(8924):746.
1993: Victoria Gerolami; Philippe Halfon; Marc Bourliere; Hacène Khiri; Pascal Reynier; P P Garnier; I Portal; A Gauthier; G Cartouzou
Hepatitis C virus genotypes in chronic hepatitis and response to interferon-alpha therapy.
The Journal of infectious diseases 1993;168(5):1328-9.